Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of the American College of Cardiology (JACC)
The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.
Cardiology August 5th 2024
MDLinx
A remarkable case of a four-year-old boy surviving a 19-hour cardiac arrest with no medical explanation of why his heart starting beating again.
Cardiology July 9th 2024